Vanguard Group Inc. Lowers Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Vanguard Group Inc. decreased its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 1.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,635,298 shares of the company’s stock after selling 54,861 shares during the quarter. Vanguard Group Inc. owned approximately 11.38% of Prestige Consumer Healthcare worth $484,467,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. Kayne Anderson Rudnick Investment Management LLC purchased a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth about $84,932,000. Congress Asset Management Co. boosted its stake in shares of Prestige Consumer Healthcare by 9.1% in the first quarter. Congress Asset Management Co. now owns 991,580 shares of the company’s stock worth $85,246,000 after buying an additional 82,838 shares during the last quarter. Westwood Holdings Group Inc. boosted its stake in shares of Prestige Consumer Healthcare by 7.1% in the first quarter. Westwood Holdings Group Inc. now owns 861,282 shares of the company’s stock worth $74,044,000 after buying an additional 56,802 shares during the last quarter. Northern Trust Corp boosted its stake in shares of Prestige Consumer Healthcare by 10.9% in the fourth quarter. Northern Trust Corp now owns 813,076 shares of the company’s stock worth $63,493,000 after buying an additional 80,055 shares during the last quarter. Finally, Bank of America Corp DE boosted its stake in shares of Prestige Consumer Healthcare by 6.4% in the fourth quarter. Bank of America Corp DE now owns 594,098 shares of the company’s stock worth $46,393,000 after buying an additional 35,830 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Analyst Ratings Changes

PBH has been the topic of a number of recent research reports. Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a “hold” rating in a research note on Thursday, May 8th. Wall Street Zen cut Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Finally, Canaccord Genuity Group reduced their price target on Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating for the company in a report on Friday, August 8th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, Prestige Consumer Healthcare has a consensus rating of “Hold” and a consensus price target of $93.33.

Prestige Consumer Healthcare Stock Performance

NYSE PBH opened at $64.60 on Friday. The stock has a market capitalization of $3.18 billion, a price-to-earnings ratio of 15.16, a PEG ratio of 2.10 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a twelve month low of $62.95 and a twelve month high of $90.04. The company has a current ratio of 4.38, a quick ratio of 2.99 and a debt-to-equity ratio of 0.55. The stock has a 50-day moving average of $77.67 and a 200 day moving average of $81.68.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The firm had revenue of $249.53 million for the quarter, compared to analyst estimates of $260.71 million. During the same period in the previous year, the company earned $0.90 EPS. Prestige Consumer Healthcare’s revenue was down 6.6% compared to the same quarter last year. Sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.